4SC
U.S. patent granted to protect 4SC's DHODH inhibitors and their use as medication
Published in Pharma Law Weekly, August 22nd, 2006
This patent protects, apart from the composition of a group of DHODH inhibitors that are chemically related to 4SC's clinical drug candidate (SC12267), also their use as a medication to treat diseases, such as rheumatoid arthritis or cancer.
"This patent is of strategic significance for a potential licensing partnership related to our most advanced project and strengthens our position in the competitive environment around autoimmune...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-08-22)
More Articles from Pharma Law Weekly
- Alnylam Pharmaceuticals
Alnylam reports loss of $0.31 per share - Biosite
Biosite notes 45% increase in sales of cardiovascular products - Business & Finance
Lincare Holdings reports Q2 revenues of $350.1 million, 11% higher than Q2 2005 - Celator Pharmaceuticals
Celator reports positive European patent decision for CombiPlex technology - Community Education Centers
Community Education Centers comments on National Institute on Drug Abuse report - EMD Chemicals
EMD Chemicals gets U.S. FDA approval for Candurin for use in drugs - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
